Netflix reported Q2 2026 revenue of $12.56 billion, up 13.4% year over year, nearly matching analyst estimates of $12.59 billion. Earnings per share came in at $0.80, beating consensus expectations of $0.79 by a slim margin.

GE Aerospace reported Q2 2026 EPS of $2.02, beating consensus estimates of $1.85 by 9.19%. Revenue reached $12.63 billion, reflecting 24% year-over-year growth.

UnitedHealth Group reported second quarter 2026 revenues of $112.0 billion. Adjusted earnings per share reached $6.38, significantly exceeding analyst expectations of approximately $4.85.

Second quarter revenue reached US$40.20 billion, up 36.0% year-over-year and 12.0% sequentially, at the high end of guidance. Diluted EPS came in at US$4.31, a 77.4% increase year-over-year, exceeding analyst estimates.

Price target: $100 per share — a major psychological milestone that Interactive Brokers Group, Inc. ( IBKR ) has not yet reached, with its 2026 intraday high sitting just below at approximately $96.82. Strongest bullish factors: Industry-leading gross margins near 91%, a capital-light automated brokerage model, double-digit revenue growth, and a debt-free balance sheet that gives management substantial financial flexibility.

IBKR closed at $92.21 on July 16, down -5.34% from the prior session's close of $97.41, with the entire decline occurring during regular market hours. The primary catalyst was the company's Q2 2026 earnings release, which disappointed investors as EPS came in at approximately $0.59 versus consensus estimates near $0.60, and revenue of roughly $1.69 billion missed expectations.

The $300 price target represents approximately 37% upside from KLAC's recent price of roughly $219 and sits above the consensus analyst target of $234 but within the range of the most optimistic Wall Street forecasts. AI-driven semiconductor demand is the strongest bullish catalyst, with wafer fab equipment (WFE) spending projected to reach $145–150 billion in 2026 and potentially $250 billion by 2028.

KLAC shares closed at $219.37, down -2.29% (-$5.13) during the regular trading session, extending a volatile stretch for the semiconductor equipment maker. The decline came despite Oppenheimer raising its price target to $260 from $200 and reiterating an Outperform rating, citing AI-driven supply constraints and accelerating capacity plans.

Both VIXY and VXX provide exposure to short-term VIX futures, targeting increases in expected S&P 500 volatility rather than equity ownership. VIXY is structured as an ETF (commodity pool), while VXX is an ETN (exchange-traded note), introducing counterparty credit risk for the latter.

FTH shares collapsed -18.33% during regular trading to $25.70, extending yesterday's -4.98% drop and marking a brutal two-day selloff from the $35+ range. The crash follows a parabolic speculative run-up that propelled shares from ~$13 in mid-June to a 52-week high of $37.90 on July 13, fueled by the company's rebranding to Faeth Therapeutics.

ELVA is down approximately -19.22% during Thursday's regular trading session, pulling back to roughly $9.50 after closing at $11.76 on Wednesday. The sell-off follows Wednesday's massive +49% surge, which was fueled by a newly announced commercial agreement with Amazon to deploy Electrovaya's Infinity Battery Technology and a warrant deal worth up to $280 million in future orders.

ABSI shares are down -16.19% in regular trading on Thursday, extending a steep multi-day selloff that has now erased roughly 29% of the stock's value in just over a week. The decline is primarily driven by aggressive profit-taking after a massive +233% year-to-date rally through early July, with the stock retreating from its $12.06 52-week high as momentum traders and short-term investors lock in gains.

MXL plunged -14.53% intraday on Thursday, falling from Wednesday's close of $88.84 to $75.93 during regular trading hours, accelerating a multi-day selloff. The drop follows Wednesday's -4.05% decline and premarket weakness, reflecting heavy profit-taking after the stock's extraordinary +406% year-to-date rally left valuations stretched at 11.4x forward sales.

FCEL shares tumbled -14.81% during Thursday's regular session, falling from a prior close of $20.25 to approximately $17.25, accelerating a multi-day selloff that began after the company's $225M dilutive equity offering was priced at $21 per share earlier this month. The decline deepened as FCEL broke decisively below the $21 offering price, a key psychological and technical level, triggering additional selling pressure and stop-loss cascades throughout the session.

AXTI dropped -14.51% during regular trading, falling from a prior close of $53.42 to approximately $45.67 on elevated intraday volume. A broad semiconductor sector sell-off dragged the group down roughly -4.7%, with AXTI leading decliners as the weakest name in the sector.

BB plunged -12.50% during regular trading hours to $9.31, extending a multi-session selloff from the July 15 close of $10.64. The primary catalyst is aggressive profit-taking following a ~180%+ year-to-date surge, as traders unwind momentum positions after the stock peaked near $13.59.

ATAI surged approximately +31.72% to $7.06 after Eli Lilly confirmed it will acquire the psychedelic drug developer in a deal valued at up to $3.8 billion. The rally was ignited in premarket trading following a Wednesday evening Bloomberg report that Lilly was in advanced buyout talks, with the official announcement confirming terms Thursday morning.

ABT surged +12.46% during Thursday's regular session after reporting Q2 2026 earnings premarket that beat estimates across key metrics. Adjusted EPS of $1.31 topped the $1.28 consensus, while revenue of $12.59B exceeded the $12.52B forecast, reflecting +13% reported sales growth year-over-year.

CHRN is trading down approximately -13.03% during regular market hours, falling from yesterday's close of $29.63 to around $25.77, giving back nearly half of the prior session's explosive gains. The sell-off follows yesterday's +28.77% surge, which was fueled by ASML's strong earnings and raised 2026 outlook that reignited enthusiasm across AI infrastructure names.

WDC is down -4.71% in regular trading today, compounding yesterday's -8.78% plunge as a memory-sector rout deepens. The selloff is driven by aggressive profit-taking after memory stocks surged Tuesday on IBM's warning that customers were redirecting spending toward servers, storage, and memory chips.